Sichuan Kelun-Biotech Biopharmaceutical H Logo

Sichuan Kelun-Biotech Biopharmaceutical H

🇨🇳
06990
CNE1000062J1

Sichuan Kelun-Biotech Biopharmaceutical H is a leading biopharmaceutical company focused on innovative cancer therapies. The company develops highly effective antibody-drug conjugates (ADCs) and specializes in the research and clinical development of novel oncology drugs.

Next Quarterly Earnings

Monday, March 22, 2027
Expected

Stock Price

Frequently asked questions

When did Sichuan Kelun-Biotech Biopharmaceutical H last report quarterly earnings?

Sichuan Kelun-Biotech Biopharmaceutical H last reported quarterly earnings on 8/17/2026 (Q2 2026). Earnings per share (EPS) came in at 1.92 HKD.

How do I add the Sichuan Kelun-Biotech Biopharmaceutical H earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Beat
Estimate:HK$0.27
Actual:HK$1.92
Difference:+HK$1.65
Price reaction (1 day):+0.4 %
Price reaction (7 days):+0.5 %
Q4 2025
Beat
Estimate:-HK$1.48
Actual:-HK$1.01
Difference:+HK$0.47
Price reaction (1 day):-4.8 %
Price reaction (7 days):+9.2 %

Company Information

Name
Sichuan Kelun-Biotech Biopharmaceutical H
Ticker Symbol
06990
ISIN
CNE1000062J1
Country
🇨🇳
China
Sector